Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.61−1.16 (-6.18%)
Close on Nov 16, 2026Market cap $2.00BP/E –Yield –
Immunome EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Immunome
Immunome has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?